Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
Authors:
- Jocelyn MaraguliaJMJocelyn Maragulia
- Andrew D. ZelenetzAZAndrew D. Zelenetz
- 1 April 2013
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 13 (2) , 106-111
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology NetworkLeukemia & Lymphoma, 2011
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialThe Lancet, 2010
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2010
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseasesBritish Journal of Haematology, 2010
- Does rituximab aggravate pre-existing hypogammaglobulinaemia?: Table 1Journal of Clinical Pathology, 2010
- Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphomaAnnals of Oncology, 2009
- Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatmentBone Marrow Transplantation, 2007
- Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteJournal of Clinical Oncology, 2005
- Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history studyBritish Journal of Haematology, 1999
- HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASEThe Lancet, 1987